Sustainable Development
ESG-Driven, Sustainably Grown, Trusted for Safety
Species Conservation and Environmental Carbon Reduction
Today, both the Cinnamomum kanehirae (Bull Camphor tree) and Taiwanofungus camphoratus are classified as protected species, and wild harvesting is strictly prohibited. Consequently, the only legal pathway for the commercial distribution of Antrodia cinnamomea is through artificial cultivation.
However, cultivating high-quality Antrodia cinnamomea is notoriously difficult, and technical standards across the industry remain inconsistent. C.S. Group has achieved a definitive breakthrough with our proprietary, patented ceramic cultivation carriers. By replacing the increasingly scarce traditional wood logs, this innovation represents a significant leap in biotechnology. Our resulting TF-15 strain offers stable, scalable production that is both safe and strictly quality-controlled. Remarkably, its morphology, aroma, and bioactive profiles are on par with wild-grade specimens.
Geographically independent cultivation, capable of deployment worldwide
Unlike traditional cultivation methods that rely on Taiwan camphor wood logs, C.S. Group has developed a patented ceramic-based cultivation substrate that enables scalable production without the limitations of cross-border supply constraints. With only controlled incubation equipment, nutrient media, and routine inoculation, production can be replicated globally—significantly expanding output capacity and strengthening the supply of Taiwanofungus camphoratus (Antrodia cinnamomea) raw materials.
Robust Support in Advanced Deep Processing Technology
Leveraging Taiwan’s cutting-edge biotechnology and our extensive expertise in advanced deep processing, we harness the well-defined pharmacological properties of Taiwanofungus camphoratus. Its applications span a diverse spectrum—from premium nutraceuticals to innovative drug development.
The developmental versatility of Antrodia cinnamomea far surpasses that of Lingzhi (Ganoderma), Ginseng, or Cordyceps, offering a strategic edge in the global market. With its multi-functional efficacy and broad therapeutic range, the brand’s growth trajectory promises extraordinary market explosiveness and a transformative outlook for the industry.
Corporate Social Responsibility (CSR)
Human Rights Policy
Our company adheres to the highest standards of Corporate Social Responsibility (CSR) and strictly follows the Ten Principles of the United Nations Global Compact. We are dedicated to championing human rights, including the protection of freedom of association and collective bargaining, the elimination of forced labor, the effective abolition of child labor, and the eradication of discrimination in respect of employment and occupation.
C.S. Group is committed to fostering a pro-human rights work environment and maintains a zero-tolerance policy toward workplace bullying and harassment. We prioritize open communication and provide transparent grievance mechanisms to cultivate a corporate culture rooted in care and mutual respect. Furthermore, to ensure employee voices are heard, we conduct formal Labor-Management Meetings on a quarterly basis, providing a structured platform for proposal submissions and collaborative dialogue.
Gender Equality and Workplace Diversity
Our company strictly complies with labor regulations to safeguard employee rights. We adhere to a principled open recruitment process, selecting candidates through standardized testing and professional interviews. Base salary for new hires is determined objectively, based on academic background, professional experience, and verified tenure; we ensure zero differentiation based on gender, race, political affiliation, or any other status. All recruitment advertisements maintain gender neutrality to ensure that job descriptions remain free from bias regarding gender or sexual orientation.
Our comprehensive compensation and benefits package includes various allowances, performance bonuses, employee profit sharing, Employee Stock Options (ESOs), and Restricted Stock Awards (RSAs). Additionally, annual salary adjustments are merit-based, determined by management after evaluating an individual’s performance and long-term development potential. Through this competitive structure, we aim to effectively motivate and retain top-tier talent.